Showing results (31-40 of 110) with videos related to
Sort By:
Pageof 11
Plos One|September 7, 2012
Early invasion of brain parenchyma by African trypanosomesUte Frevert, Alexandru Movila, Olga V Nikolskaia, et al.Elife|May 20, 2020
Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicityJoseph A Giovinazzo, Russell P Thomson, Nailya Khalizova, et al.Cell Host & Microbe|May 17, 2020
Inducible Germline IgMs Bridge Trypanosome Lytic Factor Assembly and Parasite RecognitionJoseph Verdi, Ronnie Zipkin, Elani Hillman, et al.Current Opinion in Nephrology and Hypertension|January 20, 2012
APOL1 and kidney diseaseMartin R Pollak, Giulio Genovese, David J FriedmanNature Reviews. Nephrology|February 27, 2013
APOL1 variants and kidney disease in people of recent African ancestryGiulio Genovese, David J Friedman, Martin R PollakCurrent Opinion in Nephrology and Hypertension|July 27, 2022
Treatment potential in APOL1-associated nephropathyDavid J Friedman, Lijun Ma, Barry I FreedmanThe Journal of Clinical Investigation|October 5, 2011
There's a goat behind door number 3: from Monty Hall to medicineDavid J Friedman, Laurence A Turka, Simon C RobsonJournal of the American Society of Nephrology : JASN|October 15, 2011
Population-based risk assessment of APOL1 on renal diseaseDavid J Friedman, Julia Kozlitina, Giulio Genovese, et al.The FEBS Journal|March 7, 2016
Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1Alok K Sharma, David J Friedman, Martin R Pollak, et al.Diabetes|May 3, 2007
The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathyDavid J Friedman, Helmut G Rennke, Eva Csizmadia, et al.Pageof 11